ClinicalTrials.govpublic full text
Safety and Immunogenicity of CVI-VZV-001 in Adults Aged 50 Years and Above
herpes zoster, herpes zoster vaccine, shingles, varicella zoster virus, immunogenicity, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 903652
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.